<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table2" position="float"><object-id pub-id-type="doi">10.7554/eLife.50524.006</object-id><label>Table 2.</label><caption><title>Entrenchment in the population (of sequences carrying the mutation) for four major classes of resistance mutations in HIV-1 subtype B: A DRM is entrenched in the population if at least ~50% or more of the sequences containing the mutation entrench it (i.e <inline-formula><mml:math id="inf71"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">&#916;</mml:mi><mml:mo>&#8290;</mml:mo><mml:mi>E</mml:mi></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mrow><mml:mi>w</mml:mi><mml:mo>&#8290;</mml:mo><mml:mi>i</mml:mi><mml:mo>&#8290;</mml:mo><mml:mi>l</mml:mi><mml:mo>&#8290;</mml:mo><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mrow><mml:mi>E</mml:mi><mml:mo>&#8290;</mml:mo><mml:mi>m</mml:mi><mml:mo>&#8290;</mml:mo><mml:mi>u</mml:mi><mml:mo>&#8290;</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mrow><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula>).</title><p>We catalog entrenchment in the population (of sequences carrying the mutation) for all primary DRMs appearing at ~1% frequency or more, and our study reveals mutations in response to NNRTIs are much less entrenched in the population (of sequences carrying the mutation) than others.</p><p><supplementary-material id="table2sdata1"><object-id pub-id-type="doi">10.7554/eLife.50524.007</object-id><label>Table 2&#8212;source data 1.</label><caption><title>Table showing entrenchment in the population (of sequences carrying the mutation) for primary resistance mutations against NRTIs.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-50524-table2-data1-v1.docx"/></supplementary-material></p><p><supplementary-material id="table2sdata2"><object-id pub-id-type="doi">10.7554/eLife.50524.008</object-id><label>Table 2&#8212;source data 2.</label><caption><title>Table showing entrenchment in the population (of sequences carrying the mutation) for primary resistance mutations against NNRTIs.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-50524-table2-data2-v1.docx"/></supplementary-material></p><p><supplementary-material id="table2sdata3"><object-id pub-id-type="doi">10.7554/eLife.50524.009</object-id><label>Table 2&#8212;source data 3.</label><caption><title>Table showing entrenchment in the population (of sequences carrying the mutation) for primary resistance mutations against PIs.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-50524-table2-data3-v1.docx"/></supplementary-material></p><p><supplementary-material id="table2sdata4"><object-id pub-id-type="doi">10.7554/eLife.50524.010</object-id><label>Table 2&#8212;source data 4.</label><caption><title>Table showing entrenchment in the population (of sequences carrying the mutation) for primary resistance mutations against INSTIs.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-50524-table2-data4-v1.docx"/></supplementary-material></p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>NRTIs</th><th>NNRTIs</th><th>PIs</th><th>INSTIs</th></tr></thead><tbody><tr><td>Years in therapy</td><td>32</td><td>23</td><td>24</td><td>12</td></tr><tr><td>Number of primary DRMs</td><td>18</td><td>15</td><td>13</td><td>15</td></tr><tr><td>DRMs entrenched in the population (of sequences carrying the mutation)</td><td>11 (61.1%)</td><td>1 ( 6.7%)</td><td>10 (76.9%)</td><td>13 (86.7 %)</td></tr><tr><td>Number of DRMs conferring high-level resistance</td><td>7</td><td>11</td><td>7</td><td>6</td></tr><tr><td>High-level resistance DRMs entrenched in the population (of sequences carrying the mutation)</td><td>3 (42.8%)</td><td>1 (9.1 %)</td><td>5 (71.4%)</td><td>5 (83.3 %)</td></tr></tbody></table><table-wrap-foot><fn><p>Source: Results shown in this table are based on calculations for &#8216;entrenchment in the population&#8217; (of sequences carrying the mutation) for each primary DRM occurring at ~1% frequency or more in HIV-1 RT, PR, and IN, respectively as shown in <xref ref-type="supplementary-material" rid="table2sdata1">Table 2&#8212;source data 1</xref>, <xref ref-type="supplementary-material" rid="table2sdata2">Table 2&#8212;source data 2</xref>, <xref ref-type="supplementary-material" rid="table2sdata3">Table 2&#8212;source data 3</xref> and <xref ref-type="supplementary-material" rid="table2sdata4">Table 2&#8212;source data 4</xref>. Resistance levels are determined according to Stanford HIVDB (<xref ref-type="bibr" rid="bib59">Rhee et al., 2003</xref>; <xref ref-type="bibr" rid="bib63">Shafer, 2006</xref>) mutation scores for PIs, NRTIs, NNRTIs, and INSTIs.&#160;</p></fn></table-wrap-foot></table-wrap>